Michał Tendera - Concepedia

Author

Michał Tendera

Also Known As

Adam Torbicki, Aleksander Żurakowski, Andrzej Bochenek, Authors/Task Force Members, B Dyduch-Fejklowicz, Danielle Duffy, Darrel P. Francis, David Hasdai, G. Filippatos, J C Tardif

643

Publications

178.1K

Citations

107

H-Index

113

Concepts

All Affiliations

Medical University of Silesia Assistance Publique – Hôpitaux de Paris University of Glasgow Royal Brompton Hospital Inserm

About

Michał Tendera is an author at Medical University of Silesia specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	65	14.8K
2	Public Health	23	28	11.3K
3	Health Sciences	8	8	465
4	Engineering	1	1	20
5	Biochemistry	1	1	79

Michał Tendera

166

Publications

36.3K

Citations

H-Index

Page 1

	Year	Citations
Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction Elliott M. Antman, Jean‐Pierre Bassand, Werner Klein, Journal of the American College of Cardiology Joint European SocietyCardiovascular EpidemiologyCardiovascular DiseaseHealth PolicyMyocardial Infarction	2000	4.8K
2014 ESC/EACTS Guidelines on myocardial revascularization Philippe Kolh, Stephan Windecker, Fernándo Alfonso, European Journal of Cardio-Thoracic Surgery	2014	4.2K
Effect of Carvedilol on Survival in Severe Chronic Heart Failure Milton Packer, Andrew J.S. Coats, Michael B. Fowler, New England Journal of Medicine	2001	3.1K
Third Universal Definition of Myocardial Infarction Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Journal of the American College of Cardiology Cardiovascular DiseaseThird Universal DefinitionCardiologyMedicineAtherosclerosis	2012	2.6K
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD Lars Rydén, Peter J. Grant, Stefan D. Anker, European Heart Journal Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyHealth PolicyCardiovascular Disease	2013	1.9K
Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure Milton Packer, Michael B. Fowler, Ellen B. Roecker, Circulation	2002	1.3K
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Kim Fox, Ian Ford, Philippe Gabríel Steg, The Lancet Cardiovascular DiseaseAntihypertensive TherapyClinical TrialsCardiologyPlacebo-controlled Trial	2008	1.1K
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial J. Michael Gaziano, Carlos Brotons, Rosa Coppolecchia, The Lancet ThrombosisHypertensionCardiovascular DiseaseMedicineModerate Risk	2018	849
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Kim Fox, Ian Ford, Philippe Gabríel Steg, The Lancet Heart RateCardiovascular DiseaseHealth PolicyCardiologySubgroup Analysis	2008	782
Facilitated PCI in Patients with ST-Elevation Myocardial Infarction Stephen G. Ellis, Michał Tendera, Mark de Belder, New England Journal of Medicine	2008	692

Page 1